Universe Pharmaceuticals (UPC) Receivables - Net (2020 - 2026)
Universe Pharmaceuticals (UPC) posted Receivables - Net of $15.0 million for Q1 2026, up 14.96% sequentially from $13.0 million in Q3 2025.
Universe Pharmaceuticals (UPC) Receivables - Net (2020 - 2026) Analysis & Trends
Universe Pharmaceuticals has reported Receivables - Net for 7 years, with the latest figure at $15.0 million in Q1 2026.
- Quarterly Receivables - Net changed N/A year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.0 million (changed N/A YoY) and the FY2025 annual result came in at $13.0 million, down 99.9% from the prior year.
- Receivables - Net rose to $15.0 million in Q1 2026 per UPC's latest filing, from $13.0 million in the prior quarter.
- Over five years, Receivables - Net peaked at $13.0 billion in Q3 2024 and troughed at $11.0 million in Q3 2023.
- A 5-year average of $1.6 billion and a median of $15.5 million in 2022 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2024 and 2025: Receivables - Net surged 118293.21% in 2024, then sank 99.9% in 2025.
- Over 5 years, Receivables - Net stood at $16.0 million in 2022, then plunged by 31.05% to $11.0 million in 2023, then soared by 118293.21% to $13.0 billion in 2024, then tumbled by 99.9% to $13.0 million in 2025, then rose by 14.96% to $15.0 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $15.0 million, $13.0 million, and $13.0 billion for Q1 2026, Q3 2025, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.29 Bn | 43.33 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.57 Bn | 39.92 Bn | 2.15 Bn |
| 3 | Zoetis | 32.09 Bn | 30.41 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.32 Bn | 19.66 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.91 Bn | - |
| 10 | Universe Pharmaceuticals | 2.88 Mn | -26.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.97 Mn |
| Mar 31, 2026 | 14.97 Mn |
| Sep 30, 2025 | 13.03 Mn |
| Sep 30, 2025 | 13.03 Mn |
| Sep 30, 2024 | 13.04 Bn |
| Sep 30, 2024 | 13.04 Bn |
| Mar 31, 2024 | 14.47 Mn |
| Mar 31, 2024 | 14.47 Mn |
| Sep 30, 2023 | 11.01 Mn |
| Sep 30, 2023 | 11.01 Mn |
| Mar 31, 2023 | 18.34 Mn |
| Mar 31, 2023 | 18.34 Mn |
| Sep 30, 2022 | 15.98 Mn |
| Sep 30, 2022 | 15.98 Mn |
| Mar 31, 2022 | 19.37 Mn |
| Mar 31, 2022 | 19.37 Mn |
| Sep 30, 2021 | 15.57 Mn |
| Sep 30, 2021 | 15.57 Mn |
| Sep 30, 2020 | 11.51 Mn |
| Sep 30, 2020 | 11.51 Mn |